Trevena to Present at the Cowen and Company 38th Annual Healthcare Conference
Mar 07, 2018 21:02 pm UTC| Business
CHESTERBROOK, Pa., March 07, 2018 -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at the Cowen and Company 38th Annual Healthcare Conference on Wednesday, March 14, 2018, at 8:40 a.m. ET in...
Rosetta Stone Inc. Appoints Education Industry Veteran George A. Logue to Board of Directors
Mar 07, 2018 21:02 pm UTC| Business
Arlington, VA, March 07, 2018 -- Rosetta Stone Inc. (NYSE: RST) today announced that George A. Logue has been elected to Rosetta Stone’s Board of Directors. Mr. Logue is a seasoned executive with over 40 years of...
Five Below, Inc. Announces Fourth Quarter Fiscal 2017 Earnings Conference Call
Mar 07, 2018 21:01 pm UTC| Business
PHILADELPHIA, PA, March 07, 2018 -- Five Below, Inc. (NASDAQ:FIVE), the trend-right, high-quality extreme-value retailer for tweens, teens and beyond, today announced that its financial results for the fourth quarter of...
Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update
Mar 07, 2018 21:01 pm UTC| Business
Xtampza ER prescriptions grew by 37% in the fourth quarterFDA Approval of sNDA, including Comparative OxyContin Data in labelExpanded product portfolio by licensing rights to commercialize Nucynta franchiseRevenue growth...
Vermillion to Present at the 30th Annual ROTH Conference
Mar 07, 2018 21:01 pm UTC| Business
AUSTIN, Texas, March 07, 2018 -- Vermillion, Inc. (Nasdaq:VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that Valerie Palmieri, President and Chief Executive Officer, and...
Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in March
Mar 07, 2018 21:01 pm UTC| Business
BOSTON, March 07, 2018 -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity, today announced...
Mar 07, 2018 21:01 pm UTC| Business
TUCSON, Ariz., March 07, 2018 -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it will report its financial...